Precision prevention and treatment of allergic rhinitis
-
-
Key words:
- rhinitis,allergic /
- precision prevention and treatment
-
-
[1] National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease.Toward Precision Mdedicine:Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease[M].Washington (DC):National Academies Press (US), 2011.
[2] COLLINS F S, VARMUS H.A new initiative on precision medicine[J].N Engl J Med, 2015, 372:793-795.
[3] HAMBURG M A, COLLINS F S.The path to personalized medicine[J].N Engl J Med, 2010, 363:301-304.
[4] JAMESON J L, LONGO D L.Precision medicinepersonalized, problematic, and promising[J].N Engl J Med, 2015, 372:2229-2234.
[5] PORTNOY J, MILLER J D, WILLIAMS P B, et al.Environmental assessment and exposure control of dust mites:apractice parameter[J].Ann Allergy Asthma Immunol, 2013, 111:465-507.
[6] STEWART G A, BIRD C H, KRSKA K D, et al.A comparative study of allergenic and potentially allergenic enzymes from Dermatophagoides pteronyssinus, D.farinae and Euroglyphus maynei[J].Exp Appl Acarol, 1992, 16:165-180.
[7] FERNANDEZ-CALDAS E, PUERTA L, CARABALLO L.Mites and allergy[J].Chem Immunol Allergy, 2014, 100:234-242.
[8] BOUSQUET J, KHALTAEV N, CRUZ A A, et al.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen)[J].Allergy, 2008, 63:8-160.
[9] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年, 天津)[J].中华耳鼻咽喉头颈外科杂志, 2016, 51(1):6-24.
[10] NURMATOV U, VAN SCHAYCK C P, HURWITZ B, et al.House dust mite avoidance measures for perennial allergic rhinitis:an updated cochrane systematic review[J].Allergy, 2012, 67:158-165.
[11] TOVEY E R, MARKS G B.It's time to rethink mite allergen avoidance[J].J Allergy Clin Immunol, 2011, 128:723-727.
[12] MORGAN W J, CRAIN E F, GRUCHALLA R S, et al.Results of a home-based environmental intervention among urban children with asthma[J].New Engl J Med, 2004, 351:1068-1080.
[13] TAKARO T K, KRIEGER J, SONG L, et al.The breathe-easy home:the impact of asthma-friendly home construction on clinical outcomes and trigger exposure[J].Am J Public Health, 2011, 101:55-62.
[14] FERNANDEZ-CALDAS E.Dust mite allergens:mitigation and control[J].Current Allergy Asthma Rep, 2002, 2:424-431.
[15] PORTNOY J, MILLER J D, WILLIAMS P B, et al.Environmental assessment and exposure control of dust mites:apractice parameter[J].Ann Allergy Asthma Immunol, 2013, 111:465-507.
[16] 张罗.展望慢性鼻-鼻窦炎伴鼻息肉的精准治疗[J].中华耳鼻咽喉头颈外科杂志, 2017, 52(2):81-84.
[17] BROEK J L, BOUSQUET J, AGACHE I, et al.Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016revision[J].J Allergy Clin Immunol, 2017, 140:950-958.
[18] SEIDMAN M D, GURGEL R K, LIN S Y, et al.Clinical practice guideline:allergic rhinitis[J].Otolaryngol Head Neck Surg, 2015, 152:S1-43.
[19] OKUBO K, KURONO Y, ICHIMURA K, et al.Japanese guidelines for allergic rhinitis 2017[J].Allergol Int, 2017, 66:205-219.
[20] HELLINGS P W, FOKKENS W J, BACHERT C, et al.Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis-A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement[J].Allergy, 2017, 72:1297-1305.
[21] GEVAERT P, CALUS L, VAN ZELE T, et al.Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J].J Allergy Clin Immunol, 2013, 131:110-116.
[22] GEVAERT P, VAN BRUAENE N, CATTAERT T, et al.Mepolizumab, a humanized anti-IL-5mAb, as a treatment option for severe nasal polyposis[J].J Allergy Clin Immunol, 2011, 128:989-995.
[23] BACHERT C, MANNENT L, NACLERIO R M, et al.Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis:a randomized clinical trial[J].JAMA, 2016, 315:469-479.
[24] KRUG N, HOHLFELD J M, KIRSTEN A M, et al.Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme[J].N Engl J Med, 2015, 372:1987-1995.
[25] 李靖, 孔维佳, 林江涛, 等.中国特异性免疫治疗的临床实践专家共识[J].中华结核和呼吸杂志, 2012, 35(3):163-166.
[26] BURKS A W, CALDERON M A, CASALE T, et al.Update on allergy immunotherapy:American Academy of Allergy, Asthma&Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report[J].J Allergy Clin Immunol, 2013, 131:1288-1296.
[27] WANG H, LIN X, HAO C, et al.A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients[J].Allergy, 2006, 61:191-197.
[28] 张罗, 王成硕, 王向东, 等.变应性鼻炎集群免疫治疗的疗效和安全性临床分析[J].中华耳鼻咽喉头颈外科杂志, 2008, 43(3):187-191.
[29] 王模奎, 黄英, 刘恩梅, 等.标准化屋尘螨变应原制剂治疗儿童变应性哮喘68例[J].中国新药与临床杂志, 2006, 25(12):935-938.
[30] 林小平, 高军, 郑岩, 等.标准化屋尘螨变应原疫苗治疗的疗效评价[J].中国耳鼻咽喉头颈外科, 2007, 14(1):7-10.
[31] 赵惯军, 郭宏湘, 李玉琴.特异性免疫治疗哮喘患儿30例临床观察[J].中原医刊, 2007, 34(1):64-65.
[32] WANG C M, CHANG C B, CHAN M W, et al.Dust mite allergen-specific immunotherapy increases IL4DNA methylation and induces Der p-specific T cell tolerance in children with allergic asthma[J].Cell Mol Immunol, 2017.[Epub ahead of print]
[33] FAN D C, WANG X D, WANG C S, et al.Suppression of Immunotherapy on Group 2Innate Lymphoid Cells in Allergic Rhinitis[J].Chin Med J (Engl), 2016, 129:2824-2828.
[34] ZHAO D, LAI X, TIAN M, et al.The functional IgE-Blocking factor induced by allergen-specific immunotherapy correlates with IgG4antibodies and a decrease of symptoms in house dust mite-allergic children[J].Int Arch Allergy Immunol, 2016, 169:113-120.
[35] LUO X, HONG H, TANG J, et al.Increased Expression of miR-146ain children with allergic rhinitis after allergen-specific immunotherapy[J].Allergy Asthma Immunol Res, 2016, 8:132-140.
[36] ZENG G, ZHENG P, LUO W, et al.Longitudinal profiles of serum specific IgE and IgG4to dermatophagoides pteronyssinus allergen and its major components during allergen immunotherapy in a cohort of southern Chinese children[J].Mol Immunol, 2016, 74:1-9.
[37] LAI X, LI J, XIAO X, et al.Specific IgG4production during house dust mite immunotherapy among age, gender and allergic disease populations[J].Int Arch Allergy Immunol, 2013, 160:37-46.
[38] ALHEWITI A.Adherence to long-term therapies and beliefs about medications[J].Int J Family Med, 2014, 2014:479-596.
[39] DEMOLY P, ALLAERT F A, LECASBLE M.ERASM, apharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France[J].Allergy, 2002, 57:546-554.
[40] 刘立新, 程占刚, 崔顺九.重视基层医院变应性鼻炎患者药物治疗医嘱依从性[J].中国耳鼻咽喉头颈外科, 2010, 17(12):659-659.
[41] 孟娟, 刘锋, 刘四喜, 等.变应性鼻炎专病门诊对促进疾病规范化诊疗的意义[J].中国耳鼻咽喉头颈外科, 2014, 21(5):255-258.
[42] 锡琳, 韩德民, 吕晓飞, 等.变应性鼻炎患者的心理学特点及影响因素分析[J].中华耳鼻咽喉头颈外科杂志, 2009, 44(12):982-985.
[43] 吴少皎, 陈冰, 陈实, 等.新型社交媒体管理对儿童哮喘疗效及依从性的影响[J].海南医学, 2017, 28(17):2814-2817.
[44] 孙文思, 鲍一笑.儿童哮喘管理的互联网时代[J].国际儿科学杂志, 2016, 43(7):515-518.
-
计量
- 文章访问数: 150
- PDF下载数: 103
- 施引文献: 0
下载: